BIOXCEL THERAPEUTICS INC. - COMMON STOCK
0.5848
04-10月-24 14:59:45
15 分の遅延
株式
+0.0347
+6.31%
本日の幅
0.5500 - 0.5915
ISIN
N/A
ソース
NASDAQ
-
BioXcel Therapeutics to Participate at the Canaccord Genuity 42nd Annual Growth Conference
03 8 2022 06:00:01 提供 Nasdaq GlobeNewswire
-
BioXcel Therapeutics to Report Second Quarter 2022 Financial Results on August 9, 2022
26 7 2022 06:00:00 提供 Nasdaq GlobeNewswire
-
BioXcel Therapeutics Appoints Michael P. Miller to Board of Directors
05 7 2022 06:00:01 提供 Nasdaq GlobeNewswire
-
BioXcel Therapeutics to Participate at Two Upcoming Investor Conferences
07 6 2022 06:00:00 提供 Nasdaq GlobeNewswire
-
20 5 2022 06:00:00 提供 Nasdaq GlobeNewswire
-
BioXcel Therapeutics Reports First Quarter 2022 Financial Results and Recent Operational Highlights
09 5 2022 06:00:01 提供 Nasdaq GlobeNewswire
-
BioXcel Therapeutics to Present at Three Upcoming Investor Conferences
05 5 2022 06:00:02 提供 Nasdaq GlobeNewswire
-
03 5 2022 06:00:02 提供 Nasdaq GlobeNewswire
-
BioXcel Therapeutics to Report First Quarter 2022 Financial Results on May 9, 2022
26 4 2022 06:00:01 提供 Nasdaq GlobeNewswire
-
19 4 2022 06:05:00 提供 Nasdaq GlobeNewswire
-
19 4 2022 06:00:01 提供 Nasdaq GlobeNewswire
-
10 3 2022 06:04:55 提供 Nasdaq GlobeNewswire
-
BioXcel Therapeutics to Present at the Barclays Global Healthcare Conference
09 3 2022 06:00:01 提供 Nasdaq GlobeNewswire
-
BioXcel Therapeutics to Report Fourth Quarter and Full Year 2021 Financial Results on March 10, 2022
24 2 2022 06:00:01 提供 Nasdaq GlobeNewswire
-
14 2 2022 16:00:00 提供 Nasdaq GlobeNewswire
-
BioXcel Therapeutics to Present at the SVB Leerink 11th Annual Global Healthcare Conference
09 2 2022 06:00:00 提供 Nasdaq GlobeNewswire
-
BioXcel Therapeutics Appoints Matt Wiley Chief Commercial Officer
19 1 2022 06:00:00 提供 Nasdaq GlobeNewswire
-
BioXcel Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference
04 1 2022 06:00:01 提供 Nasdaq GlobeNewswire